Want to see TSE:VHI full AI Analyst Report?
VHI Stock Chart & Stats
C$6.58
C$0.27(4.10%)
At close: 4:00 PM EDT
C$6.58
C$0.27(4.10%)
Day’s Range― - ―
52-Week RangeC$6.46 - C$13.81
Previous CloseN/A
Volume275.04K
Average Volume (3M)148.97K
Market Cap
C$500.97M
Enterprise ValueC$326.26
Total Cash (Recent Filing)C$136.51M
Total Debt (Recent Filing)C$2.86M
Price to Earnings (P/E)66.6
Beta1.19
Next Earnings
Nov 05, 2026EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.12
Shares Outstanding63,414,160
10 Day Avg. Volume164,389
30 Day Avg. Volume148,972
Financial Highlights & Ratios
PEG Ratio1.48
Price to Book (P/B)2.08
Price to Sales (P/S)5.09
P/FCF Ratio70.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$12.75Price Target Upside93.77% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)0.28
Revenue Forecast (FY)C$131.42M
Bulls Say, Bears Say
Bulls Say
Strong Net Cash PositionA large cash reserve with no debt gives durable financial flexibility: supports M&A, product investment, R&D (AI/transcription), and an NCIB without stressing operations. This reduces refinancing risk and underpins strategic optionality over the next 2–6 months.
Recurring Revenue / ARR ScaleCrossing $100M ARR and ~10% organic growth signals a durable, subscription-based revenue base. High ARR improves predictability, supports higher lifetime value, and underpins sustainable SaaS-led growth, easing customer retention and upsell strategies over the medium term.
High Margins And Improving EBITDASustained high gross margins and healthy EBITDA margins reflect scalable software economics and improving operating leverage. This margin profile supports reinvestment in product, M&A integration, and margins resilience versus cyclical services, persisting over months ahead.
Bears Say
UK/NHS Contract UncertaintyDependence on public-sector procurement outcomes creates structural regional risk: suspended use and recorded ARR reductions can lengthen sales cycles and depress recurring revenue in the U.K., limiting visibility and potential ARR growth for several quarters.
Weaker Cash ConversionLower OCF-to-net-income signals timing or working-capital stress that can reduce free cash flow resiliency. If persistent, weaker cash conversion limits internal funding for M&A, product rollouts, or buybacks despite a strong headline cash balance.
Services Revenue VolatilityA meaningful share of revenue from project-based services creates quarter-to-quarter variability and margin pressure when timing shifts. This structural lumpiness complicates forecasting and can temporarily dilute gross and EBITDA margins during integration or heavy implementation periods.
Vitalhub News
VHI FAQ
What was Vitalhub’s price range in the past 12 months?
Vitalhub lowest stock price was C$6.46 and its highest was C$13.81 in the past 12 months.
What is Vitalhub’s market cap?
Vitalhub’s market cap is C$500.97M.
When is Vitalhub’s upcoming earnings report date?
Vitalhub’s upcoming earnings report date is Nov 05, 2026 which is in 80 days.
How were Vitalhub’s earnings last quarter?
Vitalhub released its earnings results on Aug 06, 2026. The company reported C$0.03 earnings per share for the quarter, missing the consensus estimate of C$0.071 by -C$0.041.
Is Vitalhub overvalued?
According to Wall Street analysts Vitalhub’s price is currently Undervalued.
Does Vitalhub pay dividends?
Vitalhub does not currently pay dividends.
What is Vitalhub’s EPS estimate?
Vitalhub’s EPS estimate is 0.07.
How many shares outstanding does Vitalhub have?
Vitalhub has 63,414,160 shares outstanding.
What happened to Vitalhub’s price movement after its last earnings report?
Vitalhub reported an EPS of C$0.03 in its last earnings report, missing expectations of C$0.071. Following the earnings report the stock price went up 12.074%.
Which hedge fund is a major shareholder of Vitalhub?
Currently, no hedge funds are holding shares in TSE:VHI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vitalhub Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$12.75 (93.77% Upside)
C$12.75 (93.77% Upside)
Blogger Sentiment
Bullish
TSE:VHI Sentiment 100%
Sector Average 61%
Sector Average 61%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.2%
Last 30 Days ▲ 3.4%
Last 30 Days ▲ 3.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
7.33%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
37.72%
Trailing 12-Months
Company Description
Vitalhub
Vitalhub Corp., through its subsidiaries, provides innovative technological solutions to health and human service providers internationally, specifically catering to markets in Canada, the United States, the United Kingdom, Australia, and Western Asia. The company's diverse array of offerings comprises electronic healthcare records, case management systems, care coordination platforms, tools for optimizing patient flow and operational insights, and various mobile applications. Incorporated in 2010, Vitalhub is headquartered in Toronto, Canada.
VHI Stock 12 Month Forecast
Average Price Target
C$12.75
▲(93.77% Upside)
Technical Analysis
Diagnos
―
―
nDatalyze Corp
―
Comprehensive Healthcare Systems Inc
―
UniDoc Health Corp
―